plerixafor has been researched along with pyrimidinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ale-Ali, A; Amaya-Chanaga, CI; Cardarelli, PM; Castro, JE; Choi, MY; Cohen, LJ; Jones, H; Kashyap, MK; Kipps, TJ; Kuhne, MR; Kumar, D; Melo-Cardenas, J; Rassenti, LZ; Sabbatini, P; Shelat, SG | 1 |
| Bonnet, D; Bordenave, J; Cumont, A; Frossard, N; Galzi, JL; Guignabert, C; Hibert, M; Huertas, A; Humbert, M; Marsol, C; Phan, C; Savale, L; Thuillet, R; Tu, L | 1 |
| Feng, Q; Feng, Y; Hou, FF; Liu, Y; Miao, J; Shen, W; Wu, Q; Zhou, L; Zhou, S | 1 |
3 other study(ies) available for plerixafor and pyrimidinones
| Article | Year |
|---|---|
Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.
Topics: Actins; Antineoplastic Agents; Apoptosis; Benzylamines; Cell Movement; Cell Proliferation; Cell Survival; Chemokine CXCL12; Cyclams; Enzyme Activation; Heterocyclic Compounds; Humans; Imino Furanoses; Jurkat Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Pyrimidinones; Reactive Oxygen Species; Receptors, CXCR4; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2016 |
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Topics: Animals; Benzylamines; Cell Movement; Cell Proliferation; Cells, Cultured; Chalcones; Chemokine CXCL2; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Macrophages; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pericytes; Pulmonary Artery; Pyrimidinones; Rats, Wistar; Receptors, CXCR4; Signal Transduction; Vascular Remodeling; Vascular Resistance | 2020 |
C-X-C motif chemokine receptor 4 aggravates renal fibrosis through activating JAK/STAT/GSK3β/β-catenin pathway.
Topics: Amino Acid Motifs; Animals; Benzylamines; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Chemokine CXCL12; Cyclams; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; Glycogen Synthase Kinase 3 beta; Humans; Janus Kinase 2; Kidney; Matrix Metalloproteinase 7; Mice; Pyrimidinones; Receptors, CXCR4; Renal Insufficiency, Chronic; STAT3 Transcription Factor; STAT6 Transcription Factor | 2020 |